23andMe and Nightingale partner to pilot blood-based risk detection panel [Yahoo! Finance]
Quest Diagnostics Incorporated (DGX)
Last quest diagnostics incorporated earnings: 4/22 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
ir.questdiagnostics.com
Company Research
Source: Yahoo! Finance
The companies will offer 5,000 of 23andMe's premium members a chance to receive blood testing through Nightingale's Remote Health Check. The pilot will evaluate customers' feedback on the blood panel services, at-home sample collection, and the utility of the data when combined with 23andMe's genetics channels. The Nightingale's blood panel can test different biomarkers, including cholesterols, apolipoproteins and fatty acids such as Omega-3. The results can then be used to inform the presence of diseases and lifestyle interventions such as diet and exercise. The blood test results could also be used to improve the accuracy of the lifetime risk of disease prediction technology offered by 23andMe as part of its annual membership. Genetic testing is a growing area of research. There are more than 500 devices in active development for genetic testing, as per GlobalData analysis. Of these, 279 are in the late stages of development, with GlobalData predicting these tests will gain app
Show less
Read more
Impact Snapshot
Event Time:
DGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DGX alerts
High impacting Quest Diagnostics Incorporated news events
Weekly update
A roundup of the hottest topics
DGX
News
- GM to Forfeit Emissions Credits in Pollution Settlement With EPA [BNN Bloomberg (Canada)]BNN Bloomberg
- OMERS selling LifeLabs to Quest Diagnostics in deal valued at $1.35 billion [Financial Post (Toronto, Ontario, Canada)]Financial Post
- OMERS selling LifeLabs to Quest Diagnostics in deal valued at $1.35B [BNN Bloomberg (Canada)]BNN Bloomberg
- U.S.-based Quest Diagnostics buys Lifelabs for $1.35-billion [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- OMERS selling LifeLabs to Quest Diagnostics in deal valued at $1.35B [Yahoo! Finance Canada]Yahoo! Finance Canada
DGX
Earnings
- 4/23/24 - Beat
DGX
Sec Filings
- 7/3/24 - Form 8-K
- 7/2/24 - Form 4
- 6/21/24 - Form 11-K
- DGX's page on the SEC website